S

Active Director Director DIN 08183348
DIN 08183348 First appointment Jul 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2018
Shareholding value •••• Premium profile

About Shabith

Data last updated:

Shabith is a Director at Asteron Pharmaceuticals Private Limited (since 2018). The company operates in Trading. Asteron Pharmaceuticals Private Limited reported revenue of ₹2.95 Cr (FY 2025).

DIN 08183348
Primary Designation Director
Industry Trading
First Appointment 19 Jul 2018
Oldest Company Age 10 yrs
Largest company Asteron Pharmaceuticals Private Limited · ₹2.95 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jul 20182016₹2.95 Cr (FY 2025)Active

Board colleagues of Shabith

NameDINCompanyDesignation
Sandheep Pooloth07435888Asteron Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Asteron Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shabith

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shabith

Shabith currently holds 1 directorship: Asteron Pharmaceuticals Private Limited (Director, since 19 Jul 2018, revenue ₹2.95 Cr (FY 2025)).

Shabith was first appointed on 19 Jul 2018 as Director at Asteron Pharmaceuticals Private Limited.

The current boards of Shabith's companies include Sandheep Pooloth (Asteron Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available